CHCWM – Cancer & Hematology Centers of West Michigan

In the News

As the largest physician-owned oncology and hematology practice in Michigan, we are often in the news. See what we've been up to.
Dr. Eric Santos
CHC Physician and clinical trial featured in ‘Clinical Oncology News’

Cancer & Hematology Centers of Western Michigan’s Eric Santos, MD, recently spoke to Clinical Oncology News about its ongoing Prospective Clinico-Genomic study. The study, which examines how “various technologies… can be integrated to streamline and simplify clinical trials for people with Read more »


CHC Patient Care Technicians featured on WZZM13

Lacks Cancer Center Patient Care Technicians Destiny McDaniel and Julia Warren were recently featured on WZZM13’s “One Good Thing” segment. Watch the full video here. Read more »


Holland Cancer Center featured on eightWest

Our physicians Eric Batts, MD, and Kelly Parling-Lynch, recently gave a tour of our newly refurbished Holland Cancer Center on WOOD TV8’s eightWest program. See the full video here. Read more »


CHCWM and START Midwest trials presented at AACR Annual Meeting 2021

Cancer & Hematology Centers of Western Michigan (CHCWM) and START Midwest trials were presented as e-posters at last week’s American Association for Cancer Research (AACR) Annual Meeting 2021. “Expanded access program of the PLK1 inhibitor onvansertib for treatment of patients Read more »


Dr. Yuanbin Chen
CHC’s Dr. Yuanbin Chen featured in small cell lung cancer video

Cancer & Hematology Centers of Western Michigan (CHC)’s Yuanbin Chen, MD, PhD, was recently featured in AstraZenaca’s most recent Thoracic Oncology Perspectives Series video discussing extensive-stage small cell lung cancer. Watch the video here. Read more »


CHC Research physician published in ‘The Lancet’

Cancer and Hematology Centers of Western Michigan (CHC)’s Yuanbin Chen, MD, PhD, recently co-authored another publication published in the esteemed medical journal The Lancet. The article details findings from CHC’s CASPIAN trial, which studied the use of durvalumab plus platinum–etoposide as Read more »


Page 1 of 7
Page: